You just read:

Health Canada approves Tecentriq® in combination with chemotherapy (nab-paclitaxel) as first immunotherapy treatment for aggressive form of breast cancer(1)

News provided by

Hoffmann-La Roche Limited (Roche Canada)

Sep 27, 2019, 13:19 ET